Shawano County considers wheel tax: What does it mean, how would it impact residents?
SHAWANO, Wis. (WFRV) – Shawano County held a meeting open to the public on Thursday to listen to concerns, questions and thoughts about a possible 'wheel tax.'
Shawano County Administrative Coordinator Jim Davel said the idea came from the struggles that counties face in terms of revenue due to state regulations.
Study: Wisconsin pays some of the highest property taxes in the United States
'This is one way that counties can generate funding,' Davel said. 'It's specifically for our roads and bridges which are important parts of our county. We wanted to at least discuss this going forward.'
The Wheel Tax is referred to as Ordinance No. 1-25, which can be viewed at this link. It was created on January 7 by the Shawano County Highway Committee, and approved by the Executive Committee on January 15. Here is what it would entail:
$20 annual county vehicle registration fee
Revenue from fees would go toward maintaining county highways, bridges and other infrastructure
109.7 pound fish the largest harvest as three days remain in Winnebago sturgeon spearing season
The ordinance would take effect on January 1, 2026.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
2 hours ago
- The Hill
How the Trump administration's move will affect Harvard's international students
WASHINGTON (AP) — The efforts by President Donald Trump's administration to prevent Harvard University from enrolling international students have struck at the core of the Ivy League school's identity and unsettled current and prospect students around the world. Last month, the government told Harvard's thousands of current foreign students that they must transfer to other schools or they will lose their legal permission to be in the U.S. A federal court in Boston last week blocked the Department of Homeland Security from barring international students at Harvard. On Wednesday, Trump signed an executive order invoking a different legal authority to keep Harvard's international students from entering the United States. Trump has targeted Harvard's international enrollment as it presses the nation's oldest and wealthiest university to adopt a series of policy and governance changes, which the university has rebuffed. Harvard decried the latest order as retaliation and said it violates the school's First Amendment rights. 'Harvard will continue to protect its international students,' the university said in a statement. Harvard enrolls about 7,000 international students, most of them in graduate programs. Those students have been scrambling to figure out their next steps. At the center of Trump's pressure campaign against Harvard are his assertions that the school, which he has called a hotbed of liberalism, has tolerated anti-Jewish harassment. In his order, he cites a broad federal law that gives the president authority to block foreigners whose entry would be 'detrimental to the interests of the United States.' The earlier effort to ban foreign students at Harvard, which a judge put on hold, cited the Department of Homeland Security's authority to oversee which colleges are part of the Student Exchange and Visitor Program. The program allows colleges to issue documents foreign students need to study in the United States. In a lawsuit, Harvard said the administration violated the government's own regulations for withdrawing a school's certification. Harvard sponsors more than 7,000 people on a combination of F-1 and J-1 visas, which are issued to students and to foreigners visiting the U.S. on exchange programs such as fellowships. Across all the schools that make up the university, about 26% of the student body is from outside the U.S. But some schools and programs, by nature of their subject matter, have significantly more international students. At the Harvard Kennedy School, which covers public policy and public administration, 49% of students are on F-1 visas. In the business school, one-third of students come from abroad. And within the law school, 94% of the students in the master's program in comparative law are international students. While the initial effort to block international enrollment has been put on hold, the new order would keep new Harvard students from entering the country unless the government changes course. For foreign students already at Harvard, Secretary of State Marco Rubio will determine if visas should be revoked, Trump wrote. The government can and does remove colleges from the Student Exchange and Visitor Program, making them ineligible to host foreign students on their campus. However, it's usually for administrative reasons outlined in law, such as failing to maintain accreditation, lacking proper facilities for classes, failing to employ qualified professional personnel — even failing to 'operate as a bona fide institution of learning.' Other colleges are removed when they close. Harvard's battle with the Trump administration dates to early April. The storied institution became the first elite college to refuse to comply with the government's demands to limit pro-Palestinian protests and eliminate diversity, equity and inclusion policies. That kicked off a series of escalating actions against Harvard. Various federal agencies, including DHS and the National Institutes of Health, have cut their grant funding to Harvard, significantly impacting research projects conducted by faculty. Harvard has sued the administration, seeking to end the grant freeze. The administration first threatened to revoke Harvard's ability to host international students back in April. Trump also has said Harvard should lose its tax-exempt status. Doing so would strike at the school's ability to fundraise, as wealthy donors often give to tax-exempt institutions to lower their own tax burdens. Harvard awards need-based financial aid to students across its multiple schools. Unlike merit-based scholarships, which are awarded based on achievements or academic records, need-based aid is given to students depending on their ability to pay for tuition. Admissions to the undergraduate college is need-blind, including for international students, which means that a student's ability to pay full tuition is not considered during the application process. Unlike the majority of U.S. colleges and universities, international students do not disproportionately pay full tuition to attend. In a post last month on Truth Social, Trump criticized Harvard for enrolling a significant percentage of international students. 'Why isn't Harvard saying that almost 31% of their students are from FOREIGN LANDS, and yet those countries, some not at all friendly to the United States, pay NOTHING toward their student's education, nor do they ever intend to,' he wrote. 'Nobody told us that!' Most governments do not pay for their students to study abroad. With the exception of some government-funded scholarship programs, most international students pay their own tuition, receive need-based aid or earn merit scholarships from external organizations. ____ AP writers Collin Binkley and Cheyanne Mumphrey contributed. ____ The Associated Press' education coverage receives financial support from multiple private foundations. AP is solely responsible for all content. Find AP's standards for working with philanthropies, a list of supporters and funded coverage areas at
Yahoo
3 hours ago
- Yahoo
The LGL Group, Inc. Adds Over-Subscription Privilege to Outstanding Warrants, Files Post-Effective Amendment to the Related Registration Statement
Orlando, Florida--(Newsfile Corp. - June 5, 2025) - The LGL Group, Inc. (NYSE American: LGL) (NYSE American: LGL WS) ("LGL Group" or the "Company") today announced that is has added an Over-Subscription Privilege to its outstanding warrants to purchase common stock which were originally issued as a dividend to LGL Group stockholders on November 16, 2020 (the "Warrants"). The Company will file with the Securities and Exchange Commission (the "SEC") a post-effective amendment to its related registration statement on Form S-1 that, once declared effective, will permit holders to exercise the Warrants up and until to their expiration at the close of business on November 16, 2025, a Sunday, which allows holders to exercise the Warrants by the close of business on November 17, 2025 (the "Expiration Date"). Current Exercise Price of Warrants As a result of the previously announced downward adjustment of the exercise price triggered by the spinoff of M-tron Industries, Inc., five (5) Warrants are exercisable to purchase one share of common stock at an exercise price of $4.75. Addition of Over-Subscription Privilege The Company has amended the warrant agreement to add an Over-Subscription Privilege that will from and after close of business on October 16, 2025 (the "Over-Subscription Commencement Date") until the Expiration Date allow warrant holders to subscribe for additional shares of common stock that remain unsubscribed as a result of any unexercised Warrants. The total number of shares of common stock that will be available to all holders who exercise their Warrants and elect the Over-Subscription Privilege will be the number of shares which are not subscribed for as of the Expiration Date pursuant to the basic warrant exercise rights of all holders. Holders that exercise the Warrants prior to the Over-Subscription Commencement Date will not be entitled to subscribe for additional shares pursuant to the Over-Subscription Privilege. Further information concerning how to exercise LGL Group Warrants can be found on the Warrant FAQ page of the Company's website at None of the Company, its board of directors or employees has made or is making any representation or recommendation to any holder of the Warrants as to whether to exercise or refrain from exercising any Warrants. Pending Registration LGL Group will file with the SEC a post-effective registration statement on Form S-1 (No. 333-158319) that includes a prospectus relating to the offering of the shares of common stock issuable upon exercise of the Warrants. The securities being registered may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. Copies of the prospectus for the offering may be obtained, when available, for free by visiting EDGAR on the SEC website at Warrant Agent Computershare Inc. and its wholly-owned subsidiary, Computershare Trust Company, N.A. (together "Computershare"), serve as the Company's warrant agent. All holders of LGL Group's warrants should direct all questions concerning the Warrants to Computershare at: By telephone (within the U.S., U.S. territories and Canada): 1-800-546-5141 By telephone (outside the U.S., U.S. territories and Canada): 1-781-575-2765 If delivering by U.S. mail: Computershare Trust Company, N.A.c/o Voluntary Corporate ActionsP.O. Box 43011Providence, RI 02940-3011 If delivering by courier: Computershare Trust Company, N.A.c/o Voluntary Corporate Actions150 Royall Street, Suite VCanton, MA 02021 The warrant FAQs relating to their original issuance and amendments made to date can be found: About The LGL Group, Inc. The LGL Group, Inc. ("LGL," "LGL Group," or the "Company") is a holding company engaged in services, merchant investment and manufacturing business activities. Precise Time and Frequency, LLC ("PTF") is a globally positioned producer of industrial Electronic Instruments and commercial products and services. Founded in 2002, PTF operates from our design and manufacturing facility in Wakefield, Massachusetts. Lynch Capital International LLC is focused on the development of value through investments. LGL Group was incorporated in 1928 under the laws of the State of Indiana, and in 2007, the Company was reincorporated under the laws of the State of Delaware as The LGL Group, Inc. We maintain our executive offices at 2525 Shader Road, Orlando, Florida 32804. Our telephone number is (407) 298-2000. Our Internet address is LGL Group common stock and warrants are traded on the NYSE American under the symbols "LGL" and "LGL WS," respectively. LGL Group's business strategy is primarily focused on growth through expanding new and existing operations across diversified industries. The Company's engineering and design origins date back to the early 1900s. In 1917, Lynch Glass Machinery Company ("Lynch Glass"), the predecessor of LGL Group, was formed and emerged in the late 1920s as a successful manufacturer of glass-forming machinery. Lynch Glass was then renamed Lynch Corporation ("Lynch") and was incorporated in 1928 under the laws of the State of Indiana. In 1946, Lynch was listed on the "New York Curb Exchange," the predecessor to the NYSE American. The Company has a had a long history of owning and operating various business in the precision engineering, manufacturing, and services sectors. Cautionary Note Concerning Forward-Looking Statements This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as those pertaining to the Company's financial condition, results of operations, business strategy and financial needs. All statements other than statements of current or historical fact contained in this press release are forward-looking statements. The words "believe," "expect," "anticipate," "should," "plan," "will," "may," "could," "intend," "estimate," "predict," "potential," "continue" or the negative of these terms and similar expressions, as they relate to LGL Group, are intended to identify forward-looking statements. These forward-looking statements are largely based on current expectations and projections about future events and financial trends that may affect the financial condition, results of operations, business strategy and financial needs of the Company. They can be affected by inaccurate assumptions, including the risks, uncertainties and assumptions described in the filings made by LGL Group with the Securities and Exchange Commission ("SEC"), including those risks set forth under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 as filed with the SEC on March 31, 2025. In light of these risks, uncertainties and assumptions, the forward-looking statements in this press release may not occur and actual results could differ materially from those anticipated or implied in the forward-looking statements. When you consider these forward-looking statements, you should keep in mind these risk factors and other cautionary statements in this press release. These forward-looking statements speak only as of the date of this press release. LGL Group undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. Accordingly, readers are cautioned not to place undue reliance on these forward-looking statements. For these statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. No Offer or Solicitation This press release is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy common stock of the Company or any other securities and shall not constitute an offer, solicitation or sale of any securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. ### Contact: The LGL Group, To view the source version of this press release, please visit
Yahoo
4 hours ago
- Yahoo
Estrella Immunopharma, Inc. (ESLA) Doses First Patient in Higher-Dose Cohort of EB103 Phase I/II Trial
Estrella Immunopharma, Inc. (NASDAQ:ESLA) has announced a major milestone in its STARLIGHT-1 Phase I/II clinical trial, dosing the first patient in the second cohort of its dose escalation study for EB103. EB103 is an innovative CD19-redirected ARTEMIS T-cell therapy designed to treat advanced B-cell Non-Hodgkin's Lymphomas (NHL). This next phase follows a successful first cohort, which reported no dose-limiting toxicities or serious adverse events, and even saw a complete response in one patient. A technician analyzing natural killer cells, as part of an immune system study and research into therapeutical agents. The second cohort will test EB103 at a higher dose, aiming to further establish safety and efficacy. Estrella Immunopharma, Inc. (NASDAQ:ESLA)'s CEO, Cheng Liu, highlighted the therapy's potential to overcome limitations of conventional CAR-T treatments, particularly for high-risk groups such as patients with HIV-associated or CNS lymphomas, populations often excluded from current therapies. EB103 leverages proprietary ARTEMIS technology, allowing T-cells to more precisely target and destroy cancer cells. Estrella Immunopharma, Inc. (NASDAQ:ESLA)'s pipeline also includes EB104, targeting both CD19 and CD22 proteins found in most B-cell malignancies. The company's progress signals hope for broader, safer, and more effective immunotherapies for cancer and autoimmune disease patients. While we acknowledge the potential of ESLA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ESLA and that has 100x upside potential, check out our report about this READ NEXT: and Disclosure: None. Sign in to access your portfolio
